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Abstract: Understanding how the T cell memory response directed towards human
cytomegalovirus (HCMV) develops and changes over time while the virus persists is
important. Whilst HCMV primary infection and periodic reactivation is well controlled by
T cell responses in healthy people, when the immune system is compromised such as
post-transplantation, during pregnancy, or under developed such as in new-born
infants and children, CMV disease can be a significant problem. In older people HCMV
infection is associated with increased risk of mortality and despite overt disease rarely
being seen there are increases in HCMV DNA in urine of older people suggesting that
there is a change in the efficacy of the T cell response following life-long infection.
Therefore, understanding whether phenomenon such as “memory inflation” of the
immune response is occurring in humans and if this is detrimental to the overall health
of individuals would enable the development of appropriate treatment strategies for the
future. In this review we present the evidence available from human studies regarding
the development and maintenance of memory CD8+ and CD4+ T cell responses to
HCMV. We conclude that there is only limited evidence supportive of “memory
inflation” occurring in humans and that future studies need to investigate immune cells
from a broad range of human tissue sites to fully understand the nature of HCMV T cell
memory responses to lytic and latent infection.
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Dear  Matthias 
 
Ref.:  Ms. No. MMIM-D-19-00031 - GENERATION, MAINTENANCE AND TISSUE 
DISTRIBUTION OF T CELL RESPONSES TO HUMAN CYTOMEGALOVIRUS IN LYTIC AND 
LATENT INFECTION. 
 
Thank you for your kind words about our manuscript, we have now revised the review in response 
to the comments made by yourself and the reviewer.   Below we have provided a point by point 
response to each of the comments below, with our response to each point in blue type. The 
revised manuscript has incorporated the reviewers’ comments as appropriate and the changes 
have been highlighted by line number of the revised document in this letter. 
 
Response to comments: 
 
(1) I appreciate your attention to the mouse model on p.3, line 78 pp and the correct reference to 
the work by Holtappels et al (Ref. 25) who were first to show memory inflation in the year 2000 in 
JVI. With knowledge of this work, Klenerman in 2003 (Ref. 26) expanded on the previous work by 
Holtappels and arrived at the same conclusions, coining the catch phrase "memory inflation" but 
not citing Holtappels et al. for the first description. The result is that mostly only Karrer et al. is 
cited for having first described memory inflation.     
 
Please note that a debate at that time resulted in a published Erratum, which should be cited in 
the reference list along with the paper. 
 
Memory Inflation: Continous Accumulation of Antiviral CD8+ T Cells Over Time. Urs Karrer, 
Sophie Sierro, Markus Wagner, Annette Oxenius, Hartmut Hengel, Ulrich H. Koszinowski, Rodney 
E. Phillips and Paul Klenerman. J Immunol  October 1, 2003,  171  (7)  3895;  DOI: 
https://doi.org/10.4049/jimmunol.171.7.3895-b  
 
This reference has now been added to the text. [Revised document reference no.: 27] 
Level 5, Box 157 
Addenbrooke’s Hospital 
Hills Road 
Cambridge CB2 2QQ 
 
Tel: +44 (0) 1223 336862 
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Actually, Ref. 25 was first to show 
 
- Accumulation of IE1-specific CD8 T cells during latent infection 
-  Epitope-specificty in that IE1 is "inflationary" whereas others are non-inflationary, namely m04, 
M83, M84 
- Accumulation in ABSOLUTE CELL NUMBERS, not just % (see comments by Reviewer) 
- Effector-memory phenotype CD62L-minus 
- Accumulated cells are functional in that they secrete IFN-gamma upon stimulation with peptide. 
 
We have amended the text where the Holtappels et al 2000 reference is first cited to reflect these 
points.  [Revised document line nos.: 89 - 91] 
 
(2) In the list of epitopes that drive memory inflation m164 is missing. This actually was the second 
inflationary epitope identified in 2002 (still earlier than Karrrer et. al.2003) You already have this as 
reference Ref. 32 but cited it for IE1 only . Actually in Ref. 32 Holtappels et al. have identified the 
sequence of the m164 peptide and showed that this new peptide behaves inflationary like IE1.   
 
We have amended the text where the murine epitopes that drive memory inflation are discussed 
to include m164 and the Holtappels et al 2016 reference.  [Revised document line no.: 96] 
 
(3) Regarding "continous inflation" I would like to draw your attention to the fact that this is 
idealized by selecting data that fit. The truth is that the dynamics is higher, with specificities rising 
and falling. See the recent paper in Frontiers in Immunology. Holtappels et al.  2016. 
 
Thank you for this comment and bringing the Holtappels et al 2016 paper to our attention, we have 
added a reference to this observation to our discussion of fluctuations in the magnitude of HCMV 
responses over time.  [Revised document line nos.: 168 - 169] 
 
Let me also comment on some comments of the Reviewer (see below), as I disagree with the 
Reviewer in some points: 
 
(1) " Authors would greatly help the field if they could consistently point out which, if any, of the 
studies actually followed absolute cell numbers" 
 
I agree but would like to note that the first description by Holtappels in 2000 (Ref. 25) already 
showed memory inflation as increase in % IE1-specific among CD8s as well as increase in 
absolute numbers! 
 
As well as discussing the increase in absolute numbers in the murine model in our introductory 
paragraph to the main text of the review [revised document line nos.: 87 - 91].  We have clarified 
which of the cited human studies used absolute numbers in their observations [revised document 
line nos.: 113 – 114; 119; 120 – 121; 130 – 132; 137; 169 – 174; 177 – 180; 201 – 204; 209; 213].  
Furthermore we have added a small statement reflecting the importance of knowing the size of the 






(2) "response being broader in B6 and humans than in BALB/c" . The reviewer also had m164 not 
in mind (see above) and other peptides in BALB/c are intermediate in inflation. This is not a real 
difference to B6 with 4 inflationary epitopes. Further, the famous paper by Sylvester (JEM) with 
the "broad response" in humans in the title is mostly misunderstood. The response is broad on the 
polymorphic population level with high HLA coverage. Sylvester have nicely shown that the 
response in INDIVIDUALS is less broad with a median of 8, as far as I recall.  Considering that 
humans are not homozygous, unlike mouse inbred strains, there is no longer any difference 
between humans, BALB/c mice and C57Bl/6 mice.    
 
In light of your comments and the other revisions we have made to the text we have decided to 
not to reference mouse strain differences highlighted by this reviewer, and have removed the 
reference to the size of the CMV specific response in BALB/c mice. 
    
Despite my lengthy comment, actual changes will be a minimal revision, except if you wish to 
revise your British English. Please resubmit as fast as possible so that I can forward it to the 
publication Office.  
 
Thank you for this comment, we have taken the opportunity to revise the overall text to hopefully 
improve the readability of the review.  As this editing has occurred throughout the document we 
have not highlighted all of the changes here or in the main revised document. We have revised all 
sections of the text, including the abstract and the main body, hopefully the English language used 




Reviewer #1: The review by Jackson, Wills and colleagues addresses an important topic in CMV 
biology, asking critical questions related to the existence, or not, of HCMV-mediated memory 
inflation in the human immune system.  The article is generally well-written. To improve it further, 
authors should revise the review to address the points below: 
 
* The major conceptual issue in this review is that most, if not all, reviewed studies on 
memory inflation have dealt only with fractions and representation of different populations. Authors 
would greatly help the field if they could consistently point out which, if any, of the studies actually 
followed absolute cell numbers, and if they could highlight the importance of this parameter to 
distinguish absolute accumulation of different cell subsets/antigen-specific populations.  
 
As mentioned above in response to your comment we have amended the text to show which 
studies used absolute count numbers versus frequency and also added a short statement 
regarding the importance of this parameter in human studies. [Revised document line nos.: 113 – 




* Line 83, "20% of the CD8 response specific to one epitope of MCMV EI1",  should note 
that in this model (BALB/c) EI1 is extremely immunodominant in both the acute and latent phases, 






We have removed this line from the document, particularly as the earlier Holtappels et al 2000 
publication are discussed in greater detail than before.  [Revised document line nos.: 87 – 94] 
 
* Line 126 - what is the "lytic latent protein group" vs the "latent protein group"? Or was that 
a typo? Regardless, it seems that it would be more precise to name them "epitopes (or peptides) 
belonging to lytic or latent protein groups"? 
 
We have edited and amended the text to better clarify this section of the review.  [Revised 
document line nos.: 141 – 145] 
 
- Lines 70-72 : CD4 T cells cannot "…secrete IL-10 as well as antiviral effector functions". 
Please re-formulate.  Subsequent sentence (lines 72-74) - should be edited for clarity, would 
better convey meaning if it had "in contrast" rather to "and a contrast". 
 
We have edited this section to clarify the point being made.  [Revised document line nos.: 75 – 80] 
   
- Line 102, suggest to break the sentence in two; as is, the connector joins two separate 
thoughts.  
 
We have edited this sentence as suggested.  [Revised document line nos.: 110 – 114] 
 
- Line 142-144, the sentence is run-on and difficult to follow, please break the sentence and 
provide references for each point.  
 
We have edited this sentence as suggested and improved the referencing for clarity.  [Revised 
document line nos.: 161 – 165] 
 
- Line 201, discordance in singular/plural.  
 
We have edited this sentence to improve understanding.  [Revised document line nos.: 229 – 232] 
 
- Lines 332-336, three sentences in one. 
 
We have edited this sentence to improve the readability of this part of the review.  [Revised 
document line nos.: 379 – 383] 
 
We hope that the revisions we have made to the manuscript are suitable and meet your 
recommendations.  We have also added the statement regarding the issue to the title page and the 
conflict of interest statement after the acknowledgments as requested by your email of the 2nd March 
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ABSTRACT (227 words) 30 
Understanding how the T cell memory response directed towards human cytomegalovirus (HCMV) 31 
develops and changes over time while the virus persists is important.  Whilst HCMV primary 32 
infection and periodic reactivation is well controlled by T cell responses in healthy people, when the 33 
immune system is compromised such as post-transplantation, during pregnancy, or under 34 
developed such as in new-born infants and children, CMV disease can be a significant problem.  In 35 
older people HCMV infection is associated with increased risk of mortality and despite overt 36 
disease rarely being seen there are increases in HCMV DNA in urine of older people suggesting 37 
that there is a change in the efficacy of the T cell response following life-long infection.  Therefore, 38 
understanding whether phenomenon such as “memory inflation” of the immune response is 39 
occurring in humans and if this is detrimental to the overall health of individuals would enable the 40 
development of appropriate treatment strategies for the future.  In this review we present the 41 
evidence available from human studies regarding the development and maintenance of memory 42 
CD8+ and CD4+ T cell responses to HCMV.  We conclude that there is only limited evidence 43 
supportive of “memory inflation” occurring in humans and that future studies need to investigate 44 
immune cells from a broad range of human tissue sites to fully understand the nature of HCMV T 45 
cell memory responses to lytic and latent infection.  46 
 47 
KEYWORDS 48 
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REVIEW TEXT: 50 
Introduction 51 
Primary infection with human cytomegalovirus (HCMV) in healthy individuals does not generally 52 
cause overt disease [1,2], however a robust immune response is generated including neutralising 53 
antibodies and cellular responses which eventually controls and eliminates the lytic virus [3].  In the 54 
face of this immune response the virus is not cleared probably due to the numerous viral immune 55 
evasion proteins encoded by the virus [4,5] and is able to establish a latent infection in certain cell 56 
types [6].  Periodically the virus reactivates, resulting in antigenic stimulation of HCMV specific 57 
secondary immune responses and generating distinct memory CD4+ and CD8+ T cell populations, 58 
characteristic of this infection (recently reviewed in [7]).  The impact of HCMV in changing 59 
numerous immune parameters has been shown conclusively in a twin study, where identical twins 60 
varied in their HCMV infection status. It was shown that the HCMV seropositive twins had 61 
increased T cell effector memory populations and alterations in serum proteins [8].   62 
Understanding how HCMV manipulates the immune response over time during both latent carriage 63 
and periodic reactivation of the virus leading to lytic infection requires an appreciation of the virus 64 
lifecycle.  It has been shown that bone marrow resident CD34+ progenitor cells and CD14+ 65 
monocytes derived from these progenitors are sites of HCMV latent viral carriage in vivo [9].  66 
Recent transcriptomic and single cell studies have shown that latent infection is more dynamic than 67 
previously thought with a number of different transcriptional profiles of HCMV gene expression 68 
[10,11], however HCMV latent infection of CD34+ and CD14+ cells can still be characterised by the 69 
lack of infectious virion production.  Previous studies have  identified particular viral genes which 70 
are transcribed during latency and are functionally important for maintaining the latent infection, 71 
including UL138 [12,13], LUNA (latent undefined nuclear antigen; UL81-82as) [14-16], US28 72 
[17,18], UL111A (vIL-10) [19,20].  CD34+ cells latently infected in vitro with HCMV have an altered 73 
secretome which includes increased expression of chemokines that can attract CD4+ T cells as 74 
well as immune suppressive cytokines IL-10 and TGF-β [21].  In addition, it has also been shown 75 
that CD4+ T cells specific to these HCMV  proteins expressed during latency can secrete IL-10 as 76 
well as having anti-viral effector functions [22,23].  Taken together this suggests that latent HCMV 77 
infection manipulates the immune response towards a more suppressive phenotype, which is in  78 
contrast to the predominantly anti-viral effector phenotype of CD4+ T cells specific to HCMV 79 
proteins expressed during lytic infection such as pp65,IE and gB  [24]. 80 
It is important therefore to consider the impact of long-term carriage of HCMV, in some cases for 81 
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Does Memory Inflation of CMV specific T cell responses occur in humans?  85 
Memory Inflation is a phenomenon associated with cytomegalovirus infection, it has been 86 
extensively studied in the murine model of cytomegalovirus (MCMV) infection.  The expansion of 87 
IE1 specific CD8+ T cells in MCMV infection was originally described in the lungs of latently 88 
infected mice [25]. This work also demonstrated that T cells specific for other MCMV proteins were 89 
non-inflationary (m04, M83 and M84). In addition the inflationary CD8 T cells had an effector 90 
memory phenotype and retained the ability to make IFN-γ upon restimulation.  Subsequently 91 
another group described a similar observation using the term “memory inflation”, and this was 92 
observed in multiple organs and appeared to be driven by continuous activation of the T cells  93 
[26,27].  The process of “memory inflation” has subsequently been observed by other laboratories  94 
in additional mouse strains,  and a number of  MCMV proteins have been identified as driving 95 
“inflationary” responses, including m38, m139 and IE3 [28-31], m164 [32,33] and IE1/pp89 96 
[26,25,34,33,35].  The term of “memory inflation” was not precisely defined in the original work 97 
using this term [26] and recently Paul Klenerman has published an updated definition with three 98 
parts ‘(i) Restricted contraction following priming, leading to long-term maintained memory pool. (ii) 99 
A dominant and sustained “effector-memory” phenotype.  (iii) A sustained effector functionality 100 
without features of immune exhaustion’ [36].     101 
A characteristic of cytomegalovirus infection in both mice and men is the expansion of high avidity 102 
T cells clonotypes specific to the virus, in mice these populations are preferentially selected to 103 
“inflate” [37].  The contraction of the T cell Receptor (TCR) repertoire to focus on specific 104 
immunodominant HCMV protein epitopes has been observed in numerous studies over the last 105 
two decades [38], and the presence of these high affinity clones in HCMV responses, directed 106 
towards particular epitopes from the tegument protein pp65 [39-41], has been used as evidence 107 
that memory inflation occurs in the human host as well as the mouse [37,42].  The focusing of 108 
HCMV specific CD8+ T cells on particular TCR sequences, generating high affinity and avidity 109 
clones is seen against the IE1 protein as well as pp65 [43,44].  However, none of these studies 110 
show accumulation of these high affinity clones within the CD8+ T cell compartment over time. 111 
Where longitudinal studies have been undertaken, the frequency of these clones has been shown 112 
to be relatively stable over a number of years [44], once the primary response has resolved (based 113 
on absolute numbers of CD8+ T cell specific clones) [41].  Inflation of the frequency of HCMV 114 
specific T cells has been implied from a number of cross-sectional studies where increasing age of 115 
the subjects has been taken as a surrogate marker of time of HCMV carriage [45-49]. These cross-116 
sectional studies also demonstrated that  many of these T cells remained polyfunctional despite 117 
having a highly differentiated phenotype [39,44,50,51,46,52-54]. In addition it has been shown that 118 
the total CD8+ T cell pool (based on absolute numbers) expands to accommodate these CMV 119 
specific expansions [55,52]. Other studies have demonstrated a decline in the absolute numbers of 120 
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naïve T cells in older age irrespective of CMV sero-status [23,56].  These changes in absolute 121 
numbers of the T cell compartment may account for the observations of increased frequency of 122 
memory T cell populations in older CMV sero-positive donors [45-49] based on frequency of 123 
responses only.   124 
The term inflation has been used in many human studies of CMV specific T cell responses to refer 125 
to large percentages (generally greater than 1.5%) of tetramer or cytokine positive T cells 126 
responding to particular HCMV peptide epitopes [57].  Certainly, there are a number of studies 127 
showing that in some donor cohorts, there are large proportions of memory T cell responses 128 
focussed on CMV in older donors, who have likely been infected for many years compared to 129 
younger donors [45,58-60,46,48,47,49].  A limited number of studies have related this increase in 130 
magnitude of CMV specific memory T cell responses to an increase in the absolute numbers of 131 
antigen specific T cells present in donors [54,61,62].  The evidence from these studies has been 132 
used by some to support the hypothesis that an increase in the size of the CMV memory T cell 133 
population over time in humans is indicative of memory inflation.  However, other studies have 134 
shown that large expansions in the frequency of CMV specific memory T cells is a feature of being 135 
CMV positive irrespective of age, including studies of children as well as younger adults [63,51,64-136 
67], this is also true when observing the absolute size of the memory T cell compartment [23,52].   137 
Previously, we wished to investigate whether T cell responses to HCMV proteins expanded as a 138 
result of long-term carriage of the virus [23].  To address this question we have also used a cross-139 
sectional age donor cohort to investigate whether memory CD4+ and CD8+ T cell responses 140 
expand as a result of long-term viral carriage. We used pools of peptides spanning six HCMV 141 
proteins that are expressed in lytic infection (lytic antigens), that have been shown to stimulate 142 
responses in previous studies [68,24,69,70].  We also included pools of peptides spanning HCMV 143 
proteins UL138, LUNA, vIL-10 and US28, which have been shown to be expressed by latently 144 
infected cells (latent antigens).  In the paper we presented the cumulative IFN-γ responses to 145 
these lytic and latent antigens, the results showed that there was not an increase in either the 146 
breadth or magnitude of these T cell responses with increasing age.  Looking at the frequency of T 147 
cell responses to 4 immunodominant HCMV proteins (pp65, gB, IE1 and IE2) in relation to the age 148 
of the donors, clearly shows that both young and old donors can have large expansions of both 149 
CD4+ and CD8+ T cell memory responses to these lytic proteins (Figure 1).   150 
The main drawback with using cross-sectional age studies to try and identify inflationary memory 151 
responses in human subjects is the many unknowns in disease aetiology of the donors compared 152 
to murine studies.  For instance in humans the time of primary infection and the initial infectious 153 
dose are not known.  Also there  is wide genetic variability in human subjects compared to inbred  154 
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mouse strains such as C57BL/6 or BALB/c, commonly used in MCMV memory inflation studies 155 
[28,30,71-73,26,34,37,32].  156 
Longitudinal studies of individual donors where multiple samples over time have been examined, 157 
would clearly be a better approach for observing whether HCMV specific memory inflation occurs 158 
in humans, albeit technically challenging.  There have been a limited number of studies where 159 
longitudinal samples have been included, the results have provided evidence both for and against 160 
memory T cell inflation.  In an earlier study we investigated CD8+ T cell IFN-γ responses to HCMV 161 
in a small donor cohort where the frequency of T cells specific to 10 different HCMV proteins was 162 
measured in the same individuals over a period of 3 years  [68].  In this study we did not observe 163 
inflation of the CD8+ T cell functional responses, indeed despite fluctuation in the magnitude of the 164 
response at the different time points, the responses were mostly stable.  Fluctuations in the 165 
magnitude of HCMV responses have also been observed in another study over a period of 6 166 
months, however this is a short period of time and there was no net increase in T cell frequency 167 
[74]; fluctuations in the magnitude of memory responses over time is also observed in murine 168 
models [32].  An Italian cohort of 25 older donors, examined whether the magnitude (based on 169 
absolute counts of peripheral blood) of pp65 and IE1 specific IFN-γ T cell responses changed over 170 
5 years, observing a mixture of results.  There was a significant increase in the magnitude of the 171 
CD8+ T cell pp65 response, but the IE specific response remained mostly stable.  There were no 172 
significant changes in the CD4+ T cell pp65 and IE1 responses although there was an increase in 173 
the mean responses at the later time point [75].  Investigation of a CD4+ T cell HLA-DR7 restricted 174 
gB epitope in 2 HIV positive donors over 12 years, revealed stable responses to this epitope over 175 
time.  However, the frequency of the epitope specific CD4+ T cells at the start was 16% and 18%, 176 
and as such already a highly expanded memory CD4+ T cell population [57].  Investigation of the 177 
prevalence of a γδ T cell subtype, Vδ2neg, in CMV infection showed an “inflation” in this population 178 
in a cross-sectional age study but a longitudinal study measuring the absolute size of the Vδ2neg 179 
population of certain donors did not show any increases over time [76].  A recent study 180 
investigating CD8+ T cell HLA-C restricted responses does give evidence supportive of memory 181 
inflation, HLA-Cw0702 epitopes from the UL28 and IE1 proteins dominated the CD8+ T cell pool in 182 
older donors (averaging 37% of total CD8+ T cells), and in longitudinal samples from some donors 183 
there does appear to be an increase in the frequency of this response to immediate early 184 
expressed proteins [77].   185 
Within healthy adult populations, from whom many of these studies draw their participants, the 186 
unknown factor is when an individual was infected by HCMV.  It is possible that the period when 187 
memory inflation occurs post infection may be missed, as within the mouse model, inflationary 188 
responses are seen within one year of infection [26]. Therefore, it is worth investigating whether 189 
memory inflation is observable in primary HCMV infection.  Due to the generally asymptomatic 190 
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nature of HCMV infection in the majority of healthy individuals, finding and following primary natural 191 
HCMV infection is not straightforward.  One approach has been the use of a HCMV sero-positive 192 
donor kidney being transplanted into a HCMV sero-negative recipient and the subsequent viral 193 
infection, replication and primary immune responses are then followed in the recipient.  Using this 194 
model, it has been possible to elucidate the dynamics of both CD4+ and CD8+ T cell responses to 195 
HCMV and many of these patients have been followed for up to 5 years post-transplant, as such 196 
this covers a similar time period as the murine studies of memory inflation.  Key findings from this 197 
work include the importance of CD4+ T cell responses in preventing symptomatic disease, and that 198 
effector CD8+ T cells arise later but can be directly cytotoxic towards CMV presenting cells [78].  199 
This model has also been used to track the differentiation phenotype of CMV specific T cells, 200 
including the loss of co-stimulatory molecules CD27 and CD28 [79].  Many of the published studies 201 
using this model have tracked the magnitude of CMV specific T cells or tracked specific TCR 202 
clones (using both absolute counts and frequency measures), the results from these studies has 203 
provided no direct evidence of memory inflation of the CMV specific T cells [80,81,78,82,83], 204 
however, one should remember that these patients were undergoing varying degrees of 205 
immunosuppression.  In a limited number of studies where community acquired primary HCMV 206 
infection has been identified in normally healthy individuals, it has been shown that CMV specific 207 
CD8+ T cells acquire an effector phenotype during the acute phase of the infection and the 208 
numbers of CD8+ T cells increase (likely due to lymphocytosis, characteristic of natural CMV 209 
infection [1]), however by 9 months post-infection these effects are mostly resolved, although an 210 
effector memory phenotype persists [84].  In earlier studies looking at the clonality of the CMV 211 
specific CD8+ T cell response in primary infection pp65 specific responses mostly remain stable 212 
[41,59], but the frequency of IE1 specific responses may increase up to 104 weeks post infection 213 
[59].  214 
Due to the difficulties in studying the development of memory T cell responses to cytomegalovirus 215 
in humans, the use of surrogate markers, often translated from the mouse model to identify 216 
“inflationary” populations has been used.  The fractalkine receptor, CX3CR1, has been used to 217 
classify different memory CD8+ T cell populations in both mouse and human.  Expression of 218 
CX3CR1 by CD8+ T cells identifies a memory population with cytotoxic effector functions 219 
independent of other differentiation markers associated with tissue homing and other previously 220 
defined memory populations [85].  In MCMV infections CX3CR1 has been shown to be a marker 221 
expressed by intermediate peripheral memory CD8+ T cells, which are generally “inflationary” 222 
populations.  A similar population of memory CD8+ T cells expressing CX3CR1 has been identified 223 
in HCMV infected humans and this population was observed in response to an adenovirus based 224 
vaccine trial, suggesting this chemokine receptor could be used to identify “memory inflation” 225 
populations in humans [86]. CD85j (LIR1) expression on CD8+ T cells has been postulated to 226 
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identify a memory inflation population in HCMV infection [87].  The authors demonstrated that there 227 
was an increase in the total CD8+ population expressing CD85j in older donors, and that CMV 228 
sero-positivity led to a 19% increase in expression overall.  In murine studies, inflationary memory 229 
CD8+ T cell populations have an Effector Memory (EM) phenotype (defined as CD44hi, CD62L-, 230 
KLRG1+), in humans a similar EM population (defined as CCR7-, CD28-, CD27-, CD45RA-) can 231 
be identified within CMV tetramer specific CD8+ T cells [29].  Increased numbers of CMV specific 232 
EM cells results in increased numbers of CMV specific CD8+ T cells overall, this was also 233 
demonstrated in the primary kidney transplant model where the proportion of EM Tetramer+ (pp65) 234 
specific CD8+ T cells accumulates over time post-transplant [29].   235 
In addition to measuring T cell responses to CMV in cross-sectional ageing studies, the HCMV 236 
specific humoral response has often been assessed.  There is an increase in B cell numbers in 237 
CMV positive older donors [88], which could result in increased secretion of antigen specific 238 
immunoglobulins.  A number of studies have shown that CMV specific IgM [89] and IgG titres [89-239 
92] were significantly increased in older donors.  In a longitudinal study of older donors CMV IgG 240 
titres increased significantly over 5 years [75] and in donors aged over 85 years and in poor health 241 
increased IgG significantly correlated with loss of cognitive function [61].  It has been previously 242 
suggested that high CMV IgG levels correlates with high CMV-DNA levels [93], therefore we 243 
analysed whether there was a relationship between IgG titres and CMV latent viral carriage in 244 
CD14+ monocytes using the data from the donor cohort published in 2017 [23].  Within our donor 245 
cohort we did not observe an increase in latent viral load with donor age [23], in contrast to a 246 
previous study which did see an increase in latent viral load in donors over 70 years old [90].  247 
Neither did we see an increase in CMV IgG in relation to donor age (Figure 2A), in contrast to 248 
previous studies of CMV IgG titres.  We further analysed the data set to see if CMV IgG levels 249 
were related to CMV Latent Viral Load by banding the CMV IgG measure into (i) low responses, (ii) 250 
medium responses and (iii) high responses; as shown (Figure 2B) the magnitude of the CMV IgG 251 
response did not relate to latent viral load carriage.   252 
Overall, it is our view that there is not sufficient evidence to support the assertion that 253 
cytomegalovirus specific “memory inflation” occurs in humans, in contrast to the work in the murine 254 
field.  This is due to the problems in conducting such long-term longitudinal studies in humans 255 
combined with the difficulty of knowing when primary HCMV infection occurred. It is clear that 256 
younger people can have large HCMV specific T cell expansions and it might be that the main part 257 
of the inflationary stage has already occurred at the point that these individuals have been first 258 
studied. It is interesting to note that the strongest evidence for “memory inflation” in humans, has 259 
come from longitudinal studies measuring CD8+ T cell responses to immediate early HCMV 260 
proteins as first noted in the murine studies [77,59].  261 
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 262 
Is there evidence of memory inflation of CD4+ T cells secreting IL-10 in response to HCMV? 263 
Within the mouse model of “memory inflation” the focus has mainly been on CD8+ T cell 264 
responses, less work has focussed on the CD4+ T cell compartment.  There have been limited 265 
reports of memory CD4+ T cell inflation in MCMV, with evidence that CD4+ T cell responses 266 
directed to the m09 protein arise at later time points post infection and are slightly inflationary [94].  267 
In the murine model CD4+ T cells are important in controlling persistent MCMV infection in the 268 
salivary gland, by killing infected cells [95].  The salivary gland environment in MCMV infection has 269 
also been shown to contain IL-10 secreted by CD4+ T cells which prevents MCMV clearance 270 
[96,97].  The generation of a suppressive environment by CMV may be one method that the virus 271 
uses to modulate its environment to persist in myeloid lineage cells [4], certainly we have shown 272 
that latent infection of CD34+ cells results in the production of cellular IL-10 alongside the HCMV 273 
homolog vIL-10 (UL111a) and that these secretomes inhibit T cell effector function [21].  HCMV 274 
specific cells that secrete IL-10 or have a regulatory phenotype have been identified by ourselves 275 
and other research groups [22,98-100], however whether these T cells are inflated in CMV 276 
infection has not been definitively investigated.  277 
Following our previous discovery of CMV specific CD4+ T cells secreting IL-10 in response to two 278 
proteins associated with latent infection, UL138 and LUNA [22], and the evidence that there are 279 
suppressive and T regulatory cells present in CMV infection, we hypothesised that lifelong carriage 280 
of HCMV infection could create an environment where IL-10 secretion was increased by skewing 281 
the CD4+ T cell viral response towards a more suppressive phenotype.  Furthermore, modulation 282 
of the immune response to cytomegalovirus in old age, could explain the observation of CMV-DNA 283 
present in urine and blood of older donors [92,101].  We measured CD4+ T cell IL-10 responses to 284 
a range of HCMV proteins in a large donor cohort [23] as described in the previous section.  When 285 
looking at the responses to the individual proteins which generated the most frequent IL-10 286 
responses amongst the donor cohort, UL138, LUNA, US28, vIL-10, US3 and pp71 (Figure 3), we 287 
do not observe either inflation or deflation of these responses, similar to those observed to the 288 
cumulative results presented in [23]. 289 
An important consideration when looking for parallels between MCMV and HCMV studies, is the 290 
compartment where responses are being studied.  Human studies are mainly limited to looking at 291 
immune responses present in the peripheral blood compartment at one moment in time, however 292 
most of the memory inflation populations have been identified in multiple tissue sites of the mouse 293 
including the lung [37,34,25,33] , spleen [28,31] and lymph nodes amongst many sites [26,72,94].  294 
Murine work on IL-10 responses has also demonstrated that the salivary gland is an important site 295 
for observing these CMV specific CD4+ T cells [96,97].   It may be that the studies in humans 296 
trying to identify IL-10 CMV specific responses in peripheral blood have not necessarily been using 297 
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the correct compartment, although clearly any cross-sectional investigation of HCMV specific T cell 298 
frequencies in tissue sites is technically difficult let alone longitudinal studies which are probably 299 
impossible.   300 
 301 
Are there Tissue Resident HCMV specific T cell responses? 302 
Interrogating tissue resident immune responses in humans is clearly technically challenging, with 303 
most studies focus being on the peripheral blood compartment because it is easy to access and 304 
not detrimental to the health of the donor.  Other tissue sites can be accessed during medical 305 
procedures and investigations, however this may mean that the donor is unwell, although 306 
depending on individual symptoms the samples obtained may still be useable.  CMV and CMV 307 
specific T cell responses have been investigated in samples acquired via other medical 308 
procedures, including intestinal IL-10 CD4+ T cells specific for HCMV [96], alveolar macrophages 309 
from Bronchoalveolar Lavage have been shown to be sites of HCMV reactivation in vivo in the lung 310 
[102].  Secondary lymphoid organs including, Lymph nodes, spleen, bone marrow and tonsils are 311 
often removed for a variety of medical reasons, and these tissue sites have also been examined 312 
for anti-viral T cell responses [103-106].  Cadavers have been used to access multiple tissue sites 313 
from the same donor and recently CD8+ T cell responses, specific for pp65 and IE proteins, have 314 
been examined in 24 CMV sero-positive donors at multiple tissue sites including blood, Bone 315 
Marrow, Spleen, multiple Lymph Nodes and mucosal sites including the lungs and intestines.  CMV 316 
specific CD8+ T cells were identified at high frequency at several tissue sites including the lungs, 317 
blood, bone marrow and lymph nodes [107].  CD8+ T cell responses specific to pp65 and IE1 have 318 
also been observed in paired blood and lymph node samples from living donors, examination of 319 
clonal responses has shown that during CMV reactivation new clones generated in the peripheral 320 
blood do not arise from the lymph node [104], the CD8+ CMV specific T cells present in the lymph 321 
node are generally polyfunctional memory cells, with only low expression of CX3CR1 [103].  CMV 322 
specific CD8+ T cell responses have also been investigated in bone marrow specimens, this study 323 
showed an increase in Effector Memory CD8+ T cells in bone marrow samples, although the 324 
frequency of CMV specific T cells was lower in the bone marrow compared to peripheral blood in 325 
this donor cohort [106]. 326 
Most studies of HCMV specific T cells so far in tissue sites have neglected CD4+ T cell responses 327 
and functional responses, relying on phenotyping the total population and specificity by tetramers 328 
containing pp65 and IE1 derived peptides in order to quantify the antigen specific cells.  However, 329 
it is clear that there are HCMV CD4+ and CD8+ T cell responses to a much broader range of 330 
proteins than these two immunodominant proteins [70,69,50,68,24,23,22].  We have conducted 331 
preliminary studies looking at CD4+ and CD8+ T cell responses isolated from paired peripheral 332 
blood and bone marrow samples to 11 different HCMV proteins measuring IFNγ and IL-10 333 
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responses by Fluorospot (Figure 4).  The results from the CD8+ T cell compartment show that 334 
IFNγ responses to all 11 proteins are detectable in the peripheral blood, but there are no 335 
detectable CD8+ T cell responses to UL138 and LUNA in the bone marrow specimen.  When 336 
looking at CD4+ T cell responses both IFNγ and IL-10 responses show a distinct profile in the bone 337 
marrow cells compared to peripheral blood, for instance there is an IL-10 response to IE1 in the 338 
bone marrow sample, we have rarely observed IL-10 responses to this protein in peripheral blood 339 
[23].  Also, the IFNγ CD4+ T cell response to the latency associated proteins is at a higher 340 
frequency in the bone marrow sample compared to the peripheral blood sample.  This initial result 341 
suggests that it will be important to look for both IFNγ and IL-10 T cell responses to HCMV in sites 342 
other than peripheral blood. 343 
 344 
The importance of understanding anti-viral functional responses in HCMV. 345 
The studies into HCMV immune responses discussed previously have relied on identification of 346 
responses by tetramer flow cytometry, peptide or viral lysate stimulation in ELISPOT or intracellular 347 
cytokine assays, as such this studies antigen stimulation in the absence of intact functional virus 348 
expressing immune evasion molecules [5].  This contrasts with the numerous murine studies, 349 
where the “memory inflation” phenomenon can be interrogated by using viral strains with 350 
inflationary or immune evasion proteins mutated and in mice which have also been genetically 351 
manipulated to remove specific immune cell populations or irradiated and specific T cell 352 
populations adoptively transferred. In humans the immune responses we observe are a result of 353 
infection with a “wild type” virus and the effects of viral immune evasion, manipulation and 354 
modulation of the anti-cytomegalovirus immune response most likely enables the virus to persist 355 
and establish latent infections [4].  However we are not able to manipulate either the viral encoded 356 
factors or the host immune response in vivo as is possible in murine models. To improve our 357 
understanding of the generation, maintenance and functionality of HCMV specific T cell responses 358 
requires development of appropriate in vitro experimental models, where gene editing approaches 359 
and analysis of isolated immune cell populations can be performed. 360 
We have developed a viral dissemination assay utilising primary dermal fibroblasts from individual 361 
donors, grown from a 2mm punch biopsy (Figure 5A), which allows the measurement of CD8+ T 362 
cell anti-viral functionality in a fully autologous system (Figure 5B) [68], and we have modified the 363 
assay to allow the interrogation of NK cells [108] and both CD4+ and CD8+ T cells anti-viral 364 
responses against lytic infection in myeloid cells [24], furthermore the myeloid cell based assay will 365 
also allow the interrogation of immune cell interactions with experimental latent infection in 366 
monocytes (Figure 5C).   367 
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The viral dissemination assay has shown that pp65, IE1, pp71 and US3 specific CD8+ T cells are 368 
able to control the spread of the virus, this direct anti-viral control is present in CMV specific CD8+ 369 
T cells isolated directly ex vivo from peripheral blood [68].  Using a version of this assay (Figure 370 
5B), the role of NK cells expressing the inhibitory receptor LIR1 to control viral spread was 371 
elucidated [108].  Ongoing investigations have shown that CMV specific CD8+ T cell responses in 372 
isolation are effective in preventing the spread of the virus encoding a full complement of immune 373 
evasion molecules, by keeping the virus static in cells, but removal of CD8+ T cells from the 374 
dissemination assay allows the virus to restart spreading through the dermal fibroblast monolayer.  375 
However when using a mutant cytomegalovirus with US2-11 genes deleted in the viral 376 
dissemination assay, this HCMV gene region encodes immune evasion molecules that interfere 377 
with antigen processing and presentation pathways [5], ex vivo CD8+ T cells alone are virucidal 378 
(data not shown).  Co-culture of whole PBMC with clinical strains of the virus (expressing all 379 
immune evasion genes) was virucidal. We hypothesise that the interaction between the different 380 
immune cell subsets (CD4/8+ T cell, NK cells and Monocytes)  augments the cell mediated 381 
response overcoming virus mediated immune evasion and leading to killing of virus infected cells. 382 
The mechanism of this virucidal activity is currently being investigated. 383 
Using the modified viral dissemination assay (Figure 5C), we have shown that CD4+ T cells 384 
isolated from CMV sero-positive donors are able to control viral dissemination at very low effector 385 
to target (E:T) ratios and that CD4+ T cells from CMV sero-negative donors cannot [24].  In this 386 
study we had one donor aged over 70 years, and at the lowest E:T ratios their CD4+ T cells were 387 
not controlling viral dissemination as efficiently as the 4 younger donors analysed, suggesting that 388 
there may be a slight loss of quality in the functional control of viral dissemination in older CMV 389 
sero-positive donors.  The loss of quality of the anti-cytomegalovirus immune response in older 390 
donors may explain why reactivating virus is detected in urine from older and not younger donors 391 
[92].  Utilising both the fibroblast and myeloid cell based viral dissemination experimental models 392 
will enable the interrogation of whether tissue resident anti-HCMV T cells are more effective at 393 
controlling viral dissemination than T cells isolated from peripheral blood, and whether different T 394 
cell memory populations (e.g. effector memory or CX3CR1+ memory) have differing abilities to 395 
control the spread of or kill HCMV infected cells. 396 
 397 
Conclusion 398 
Investigation of T cell responses to HCMV are challenging but appropriate study design such as 399 
conducting more longitudinal studies in a wider range of donor cohorts will help to elucidate 400 
whether “memory inflation” is a phenomenon that occurs.  Also these studies will enable a greater 401 
understanding of how HCMV specific T cell memory evolves over time in the human host. 402 
Furthermore increasing the breadth of cytomegalovirus protein responses analysed including using 403 
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intact wildtype virus in assays that measure anti-viral effector function will more closely replicate 404 
the work performed in the MCMV model system.  Performing analyses of T cell responses from a 405 
wider range of tissue sites and utilising a range of functional outputs in the face of viral immune 406 
evasion strategies will increase our understanding of the maintenance of the immune response to 407 
HCMV in both lytic and latent infection. Such a fundamental understanding of the immunobiology 408 
of HCMV should inform strategies to better target the virus and possibility of removing latent virus 409 
infected cells to reduce complications of virus reactivation in the immunosuppressed transplant 410 
setting. 411 
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FIGURE LEGENDS 787 
Figure 1 – CD4+ and CD8+ T cell IFN-γ responses to pp65, gB, IE1 and IE2 HCMV proteins 788 
The T cell IFN-γ responses measured by fluorospot versus donor age from the ARIA study [23] to 789 
four lytic expressed HCMV proteins pp65 (green), gB (light blue), IE1 (dark blue) and IE2 (purple) 790 
are shown.  There is no significant correlation (Spearman rank correlation test) between the 791 
magnitude of the IFN-γ response with donor age for any of the four proteins shown. 792 
Figure 2 – CMV IgG response related to Age and Latent CMV load in CD14+ monocytes. 793 
Serum HCMV IgG levels [immune system ratio (ISR)] from the ARIA study [23] related to donor 794 
age (A); there is no significant correlation (Spearman rank correlation test).  Latent CMV Load in 795 
CD14+ monocytes measured by droplet digital PCR as previously described [23] is shown related 796 
to low (<3.5 ISR), medium (3.5 – 4.99 ISR) and high (>5 ISR) CMV IgG levels (B); there is no 797 
significant difference in the magnitude of the latent viral load between the three groups (Kruskall-798 
Wallis ANOVA test and Dunn’s multiple comparison post-test). 799 
Figure 3 – CD4+ T cell IL-10 responses to UL138, LUNA, US28, vIL-10, US3 and pp71 HCMV 800 
proteins.   801 
The CD4+ T cell IL-10 responses measured by fluorospot versus donor age from the ARIA study 802 
[23] to six HCMV proteins UL138 (turquoise circles), LUNA (turquoise squares), US28 (blue 803 
triangles), vIL-10 (blue inverted triangles), US3 (green diamonds) and pp71 (orange hexagons) are 804 
shown.  There is no significant correlation (Spearman rank correlation test) between the magnitude 805 
of the IL-10 response with donor age for any of the six proteins shown. 806 
Figure 4 – CD8+ T cell IFN-γ responses and CD4+ T cell IFN-γ and IL-10 responses in paired 807 
peripheral blood and Bone Marrow samples.  808 
IFN-γ and IL-10 T cell responses to 11 HCMV proteins were measured by fluorospot as previously 809 
described [23] in a peripheral blood and bone marrow sample from the same donor.  The CD8+ T 810 
cell IFN-γ (top graph – pink bars), the CD4+ T cell IFN-γ (middle graph – blue bars) and the CD4+ 811 
T cell IL-10 (bottom graph – turquoise bars) responses in the two compartments are shown.   812 
Figure 5 – Illustration of the viral dissemination assay model system. 813 
A schematic of the generation of autologous primary dermal fibroblasts from a 2mm punch skin 814 
biopsy sample and a microscope image (x10 magnification - bright field) of the fibroblasts growing 815 
from a portion of the skin biopsy are shown (A).  A pictorial representation of the experimental 816 
protocols of the viral dissemination assay (B) and the myeloid cell based modified viral 817 
dissemination assay (C) are shown. 818 
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